Inception Return
(11/1/2002)
|
3.64 %
|
|
YTD Return
|
-22.46 %
|
|
NAVPS
(2/6/2023)
|
$18.80
|
|
Change
|
($0.21) / -1.08 %
|
|
|
Growth of $10,000
(As of December 31, 2022)
|
|
MER
|
2.04 %
|
|
Assets ($mil)
|
$613.27
|
|
Rank (1Yr)
|
744/774
|
|
Std Dev (3Yr)
|
14.28 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
2.50 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objective of the Fund is to provide long-term growth of capital through investments in a portfolio comprised primarily of securities of large-capitalization issuers located outside North America.
|
Fund Manager
Capital Group
Portfolio Manager
Eu-Gene Cheah, Capital Group
Winston Philip, Capital Group
Victor D. Kohn, Capital Group
Michael Cohen, Capital Group
Gerald du Manoir, Capital Group
Sub-Advisor
Michael Cohen, Capital Research and Management Company
|
|
Asset Allocation
(As of September 30, 2022)
|
Sector Allocation
(As of September 30, 2022)
|
Geographic Allocation
(As of September 30, 2022)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| United States Treasury 0.00% 01-Nov-2022 | Cash and Equivalents | Cash and Cash Equivalent | United States | 3.48% |
| ASML Holding NV | International Equity | Technology | European Union | 2.40% |
| AstraZeneca PLC | International Equity | Healthcare | European Union | 2.19% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 2.15% |
| Keyence Corp | International Equity | Industrial Goods | Japan | 2.11% |
| Taiwan Semiconductor Manufactrg Co Ltd | International Equity | Technology | Asia/Pacific Rim | 2.08% |
| Genmab A/S | International Equity | Healthcare | European Union | 2.00% |
| United States Treasury 0.00% 04-Oct-2022 | Cash and Equivalents | Cash and Cash Equivalent | United States | 1.95% |
| Evolution AB (publ) | International Equity | Consumer Services | European Union | 1.95% |
| AIA Group Ltd | International Equity | Financial Services | Asia/Pacific Rim | 1.85% |
Performance Data
(As of December 31, 2022)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.29
|
13.45
|
8.49
|
-22.46
|
-22.46
|
-2.03
|
1.79
|
6.53
|
|
Benchmark
|
0.27
|
15.66
|
11.07
|
-10.67
|
-10.67
|
1.69
|
2.64
|
8.12
|
|
Quartile Ranking
|
3
|
2
|
3
|
4
|
4
|
4
|
3
|
3
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-22.46
|
3.61
|
17.05
|
22.64
|
-5.28
|
25.97
|
0.87
|
8.90
|
-0.93
|
25.73
|
|
Benchmark
|
-10.67
|
8.97
|
8.01
|
16.27
|
-6.81
|
18.37
|
-1.70
|
19.41
|
4.12
|
32.41
|
|
Quartile Ranking
|
4
|
4
|
1
|
1
|
2
|
1
|
2
|
4
|
4
|
3
|